T0	Participants 49 80	gynaecologic oncologic surgery:
T1	Participants 314 347	gynaecological oncologic surgery.
T2	Participants 416 520	102 consecutive women undergoing gynaecologic cancer surgery with pelvic and paraaortic lymphadenectomy.
T3	Participants 841 908	The two groups were well matched for age, weight, and other factors